Adhera Therapeutics Inc (ATRX) Return on Investment ROI from the second quarter of 2023 to second quarter of 2022 and for the year 2023, average high and low, overall ranking from Jun 30 2023 to Jun 30 2022 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Adhera Therapeutics Inc   (ATRX)


Adhera Therapeutics Inc's ROI from its second quarter of 2023 to the second quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Adhera Therapeutics Inc's ROI in the second quarter of 2023?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Adhera Therapeutics Inc 's return on investment (ROI) in its second quarter of 2023

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter
Y / Y Investment Change TTM - - - - -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions -23 -23 -22 -22 -20
Return On Investment (TTM) - - - - -
ATRX's Overall Ranking # # # # #
Seq. Investment Change TTM - - - - -
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -3 -3 -2 -6 -4

ATRX Company Profile >> Back to ATRX Roi Comparisons >> See Annual ATRX Return On Investment



Return On Investment ATRX's Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Investment Statistics
High Average Low
0 %
0 %
0 %
 







Financial Statements
Adhera Therapeutics Inc's II. Quarter Investments $ -23 Millions ATRX's Balance sheet
Adhera Therapeutics Inc's II. Quarter Income $ 0 Millions Quarterly ATRX's Income Statement
ATRX's Income by Division See ATRX's Income by Division


ATRX Annual Return On Investment (Dec 31 2022)
2022



Total Investments in Millions -22 0 0 0 0
Y / Y Investment Growth - - - - -
Net Income in Millions -2 0 0 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment - - - - -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ATRX's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ATRX's Competitors
Subscribers only: Roi for Adhera Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for ATRX's Customers

Other Ratios
ATRX's Roa ATRX's Inventory Turnover Ratio ATRX's Growth Rates ATRX's Dividend Statistics
ATRX's Profitability Ratios ATRX's Asset Turnover Ratio ATRX's Dividend Growth
ATRX's Roe ATRX's Valuation Ratios ATRX's Financial Strength Ratios ATRX's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2023, within Healthcare Sector ROI
Harmony Biosciences Holdings inc   32.96 %
Assertio Holdings inc   32.25 %
Denali Therapeutics Inc   30.56 %
Semler Scientific inc   30.26 %
Nrc Health  30.00 %
Tao Synergies Inc   29.39 %
Pro dex Inc   26.52 %
Arcturus Therapeutics Holdings Inc   25.44 %
Protalix Biotherapeutics inc   24.37 %
Point Biopharma Global Inc   22.31 %
Vertex Pharmaceuticals Inc  21.55 %
Iradimed Corporation  20.01 %
Eli Lilly And Company  19.95 %
Exicure Inc   19.69 %
Corcept Therapeutics Inc  19.22 %
Innoviva Inc   19.15 %
Escalon Medical Corp   19.10 %
Zoetis Inc   18.60 %
Waters Corporation  18.58 %
Chemed Corporation  18.20 %
Edwards Lifesciences Corporation  18.17 %
Siga Technologies Inc  17.68 %
West Pharmaceutical Services Inc   16.86 %
Regeneron Pharmaceuticals Inc   16.83 %
Resmed Inc   16.52 %
Zynex inc   16.45 %
United Therapeutics Corporation  14.83 %
Omeros Corporation  14.74 %
Ufp Technologies Inc   14.68 %
Hca Healthcare Inc   14.67 %

Date modified: 2026-09-08T15:11:03+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.